跳至主要内容
临床试验/CTRI/2008/091/000203
CTRI/2008/091/000203已完成4 期

SASHFR (South Asian Systolic Heart Failure Registry) : A multi-center, nonrandomized, prospective study to collect data pertaining to the demographic and cardiovascular profiles, management strategies and clinical outcomes of HF patients. - SASHFR Registry

India Medtronic Pvt Ltd0 个研究点目标入组 502 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
502

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient has signed and dated study informed consent.
  • Patients having moderate to severe heart failure (NYHA Class III or IV)
  • EF < 35% as measured by echo, MUGA, contrast ventriculogram or MRI.
  • QRS duration > 120 ms.
  • Sinus rhythm
  • Patient is willing to remain available for follow-up visits.
  • Patient is willing and able to comply with the protocol.

排除标准

  • Patient has life expectancy of less than 12 months due to medical conditions other than HF
  • Patient has experienced unstable angina, acute myocardial infarction (MI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) within the past 3 months.
  • Patient is known to have chronic permanent atrial arrhythmias (i.e., cases of long-standing atrial fibrillation of greater than 1 year, including those in which cardioversion has not been indicated or attempted).
  • Patient is enrolled in any concurrent study that would confound the results of this study.
  • Patient is pregnant or breastfeeding
  • Patient has a CRT device implanted previously.
  • Patient has had a heart transplant.

研究者

相似试验